Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
ZLAB Quote, Financials, Valuation and Earnings
Last price:
$35.99
Seasonality move
:
-6.9%
Day range:
$35.02 - $35.81
52-week range:
$16.01 - $44.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.62x
P/B ratio:
4.83x
Volume:
271.7K
Avg. volume:
868.5K
1-year change:
90.9%
Market cap:
$3.9B
Revenue:
$399M
EPS (TTM):
-$2.40
Earnings Data
Next earnings date for ZLAB
Aug 07
2025
Most recent earnings per share
-$0.40
Beat by $0.15
(May 8/2025)
Consensus Estimate
-$0.55
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZLAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $153.7M | -- | -- | -$0.29 | -- |
| 08/07/2025 | Q2 | $125M | -- | -- | -$0.42 | -- |
| 05/08/2025 | Q1 | $115.9M | $106.5M | -$0.40 | -$0.55 | $0.15 |
| 02/27/2025 | Q4 | $110.1M | $109.1M | -$0.80 | -$0.63 | -$0.17 |
| 11/12/2024 | Q3 | $102.2M | $102.3M | -$0.40 | -$0.78 | $0.38 |
| 08/06/2024 | Q2 | $93.1M | $100.5M | -$0.80 | -$0.73 | -$0.07 |
| 05/08/2024 | Q1 | $75.2M | $87.1M | -$0.50 | -$0.92 | $0.42 |
| 02/27/2024 | Q4 | $72.1M | $65.8M | -$1.00 | -$0.87 | -$0.13 |
| 11/07/2023 | Q3 | -- | -- | -$0.70 | -$1.03 | $0.33 |
| 08/07/2023 | Q2 | -- | -- | -$1.30 | -$0.81 | -$0.49 |
| 05/09/2023 | Q1 | -- | -- | -$0.50 | -$0.97 | $0.47 |
| 03/01/2023 | Q4 | -- | -- | -$0.60 | -$1.11 | $0.51 |
| 11/09/2022 | Q3 | -- | -- | -$1.70 | -$1.25 | -$0.45 |
| 08/09/2022 | Q2 | -- | -- | -$1.40 | -$1.08 | -$0.33 |
| 05/10/2022 | Q1 | -- | -- | -$0.90 | -$1.23 | $0.33 |
| 03/01/2022 | Q4 | -- | -- | -$2.28 | -$1.31 | -$0.97 |
| 11/09/2021 | Q3 | -- | -- | -$1.01 | -$1.27 | $0.26 |
| 08/10/2021 | Q2 | -- | -- | -$1.76 | -$1.39 | -$0.37 |
| 05/10/2021 | Q1 | -- | -- | -$2.64 | -$2.30 | -$0.34 |
| 03/01/2021 | Q4 | -- | -- | -$0.87 | -$0.40 | -$0.47 |
| 09/30/2020 | Q3 | -- | -- | -- | -$0.40 | -- |
| 08/13/2020 | Q2 | -- | -- | -$1.08 | -$0.99 | -$0.09 |
| 06/24/2020 | Q1 | -- | -- | -- | -$0.99 | -- |
| 03/19/2020 | Q4 | -- | -- | -$0.68 | -$0.60 | -$0.08 |
| 11/29/2019 | Q3 | -- | -- | -$0.98 | -$0.63 | -$0.35 |
| 09/03/2019 | Q2 | -- | -- | -- | -$0.67 | -- |
| 03/07/2019 | Q4 | -- | -- | -- | -$0.45 | -- |
| 08/30/2018 | Q2 | -- | -- | -- | -$0.38 | -- |
| 05/02/2018 | Q1 | -- | -- | -- | -$0.28 | -- |
| 12/31/2017 | Q4 | -- | -- | -- | -$0.17 | -- |
| 09/30/2017 | Q3 | -- | -- | -- | -$0.23 | -- |
Zai Lab Earnings Questions
-
How Much did Zai Lab Generate in Revenue Last Quarter?
Zai Lab reported $106.5M worth of top line sales in its most recent quarter.
-
Did Zai Lab Beat Earnings Last Quarter?
Zai Lab announced earnings per share of -$0.40 which represents a beat of analyst forecast a -$0.55 per share.
-
Is Zai Lab Profitable?
Zai Lab reported $67.8M that represents $0.63 per share over the last quarter.
-
What is the Analyst Consensus for Zai Lab EPS Next Year?
Zai Lab's earnings are forecast to decrease from -$2.60 per share to -$2.69 per share next year representing a decrease of -45.59%.
-
When is Zai Lab's Earnings Date?
Zai Lab's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
